Stephen A. Howard

Pharmaceutical combinations of oxycodone and naloxone

Tamper resistant transdermal dosage form

Disposal system for transdermal dosage form

Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer

Transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer and one fluid communication between the surface of the active agent and the adverse agent

Pharmaceutical combination preparation of oxycodone and naloxone

DOSIS TRANSDERMICA RESISTENTE A LAS INTERFERENCIAS, QUE COMPRENDE UN COMPONENTE DE AGENTE ACTIVO Y UN COMPONENTE DE AGENTE NOCIVO EN EL SITIO DISTAL DE LA CAPA DEL AGENTE

TRANSDERMAL DOSAGE FORM COMPRISING AN ACTIVE AGENT COMPONENT AND AN ADVERSE AGENT COMPONENT IN A RATIO FROM 1:10 UP TO 10:1

Formes posologiques transdermiques contenant un principe actif et un antagoniste de ce principe actif avec rapport de 1:10 à 10:1

Forme posologique transdermique a fermeture inviolable